Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COLLPLANT BIOTECHNOLOGIES LTD.

(CLGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/16/2021 09/17/2021 09/20/2021 09/21/2021 09/22/2021 Date
16.88(c) 16.8272(c) 16(c) 16.01(c) 16.7(c) Last
891 6 061 16 321 15 819 11 473 Volume
-0.65% -0.31% -4.92% +0.06% +4.31% Change
More quotes
Estimated financial data (e)
Sales 2021 51,2 M 16,0 M 16,0 M
Net income 2021 6,33 M 1,98 M 1,98 M
Net Debt 2021 - - -
P/E ratio 2021 83,5x
Yield 2021 -
Sales 2022 137 M 42,8 M 42,8 M
Net income 2022 97,7 M 30,5 M 30,5 M
Net Debt 2022 - - -
P/E ratio 2022 8,31x
Yield 2022 -
Capitalization 548 M 171 M 171 M
Capi. / Sales 2021 10,7x
Capi. / Sales 2022 4,00x
Nbr of Employees 52
Free-Float 75,7%
More Financials
Company
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen). 
More about the company
Ratings of CollPlant Biotechnologies Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about COLLPLANT BIOTECHNOLOGIES LTD.
09/09COLLPLANT BIOTECHNOLOGIES : CEO Yehiel Tal elected to the Board of Directors of the Intern..
PU
09/09COLLPLANT : CEO Yehiel Tal elected to the Board of Directors of the International Society ..
PR
09/07COLLPLANT : To Present at the H.C. Wainwright Annual Global Investment Conference in Septe..
PR
08/19COLLPLANT BIOTECHNOLOGIES : Provides Business Updates and Second Quarter 2021 Financial Re..
PU
08/19Collplant Biotechnologies Ltd. Reports Earnings Results for the Second Quarter Ended Ju..
CI
08/19COLLPLANT : Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors
PR
08/19CollPlant Appoints Alisa Lask to Board of Directors
CI
08/19COLLPLANT BIOTECHNOLOGIES : Earnings Flash (CLGN) COLLPLANT Posts Q2 Revenue $691,000
MT
08/19COLLPLANT BIOTECHNOLOGIES : Earnings Flash (CLGN) COLLPLANT Reports Q2 Loss $-0.25
MT
08/19COLLPLANT : Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Re..
PR
08/16COLLPLANT : Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D ..
PR
06/25COLLPLANT BIOTECHNOLOGIES : NOTICE OF ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOL..
PU
06/22SECTOR UPDATE : Health Care Stocks Manage Narrow Rise as Biotechs Flatten
MT
06/22SECTOR UPDATE : Health Care Stocks Erasing Mid-Morning Weakness
MT
06/223D : CollPlant to Co-Develop Regenerative Soft Tissue Matrix for Breast Reconstruction
MT
More news
News in other languages on COLLPLANT BIOTECHNOLOGIES LTD.
08/19Earnings Flash (CLGN) COLLPLANT affiche un revenu de 691 000 $ au deuxième trimestre
08/19EARNINGS FLASH (CLGN) COLLPLANT ANNO : 0,25 $.
More news
Analyst Recommendations on COLLPLANT BIOTECHNOLOGIES LTD.
More recommendations
Chart COLLPLANT BIOTECHNOLOGIES LTD.
Duration : Period :
CollPlant Biotechnologies Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 16,70 $
Average target price 26,13 $
Spread / Average Target 56,5%
EPS Revisions
Managers and Directors
Yehiel Tal Chief Executive Officer
Eran Rotem Chief Financial Officer & Deputy CEO
Roger J. Pomerantz Independent Chairman
Oded Shoseyov Chief Scientist
Nadav Orr Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
COLLPLANT BIOTECHNOLOGIES LTD.55.06%171
MODERNA, INC.321.86%177 895
GILEAD SCIENCES, INC.22.52%89 497
BIONTECH SE316.17%81 938
WUXI APPTEC CO., LTD.36.63%69 841
REGENERON PHARMACEUTICALS33.94%67 273